Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-05

Clinical Trial Update: A 12 Week Study to Assess Changes in Joint Inflammation Using Ultrasonography in Patients With Rheumatoid Arthritis (RA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating changes in joint inflammation via ultrasonography in rheumatoid arthritis patients was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: UCB Pharma | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2012-12-05